OrbiMed Capital GP VI LLC, Director, 10% Owner at Compass Therapeutics, Inc. (CMPX), sold 7,142,856 shares at $1.59 ($11.4M) on 2025-04-09, disclosed to the SEC on 2025-04-11.
Open-market sale of $11.4M CMPX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.59 | 3,571,428 | $5.7M | 50.0% |
| 2 | $1.59 | 3,571,428 | $5.7M | 50.0% |
| Total | $1.59 avg | 7,142,856 | $11.4M | 100% |
| Filing → |
| SCPH | BUY | 2024-08-15 | $2.0M | — | Filing → |
| NPCE | SELL | 2024-04-18 | $435K | — | Filing → |
| NPCE | SELL | 2024-04-15 | $14.1M | — | Filing → |